Triple Giving November OMF logo

 TRIPLE YOUR IMPACT during Triple Giving November | All Donations to OMF are TRIPLED through December 3

Search
Close this search box.

Neuroendocrine, Vascular and Metabolism in ME/CFS, POTS and Long COVID

Study Aim

The study aims to explore the structural, neuro-vascular, and biochemical differences in the brains of individuals with ME/CFS, Long COVID, and POTS to elucidate the underlying pathology and identify potential targets for effective treatment strategies.

Investigators

  • Xiaoyun Wang, PhD
  • Elena Christopoulos
  • Natalie Thomas, PhD
  • David Fineberg, MBBS, FRACGP, DCH
  • Paul Gooley, PhD
  • Leigh Johnston, PhD
  • Rebecca Glarin, BApSc, PGDip(MRI)
  • Rob Williams
  • Bradford Moffat, PhD
  • Christopher Rowe, BMBS, FRACP, MD, FAANMS
  • Christopher Armstrong, PhD

Updates and Potential

  • Ethics approval received.
  • Includes hand grip strength as an exertion test in the MRI/MRS.
  • Recruitment is beginning.
STUDY HYPOTHESIS AND DESCRIPTION

Emerging evidence suggests a potential link between ME/CFS and Long COVID, characterized by similar symptomatology. Additionally, POTS frequently co-occurs with ME/CFS and LC, further complicating symptom management and reducing patients’ quality of life.

Neuroinflammation has recently gained attention as a potential mechanism underlying ME/CFS and LC, with proposed pathways involving sustained glial activation and hypothalamic neuroinflammation. Glutamate dysregulation in the central nervous system, possibly exacerbated by neuroinflammation, may contribute to neuroendocrine dysfunction observed in ME/CFS and LC. Furthermore, reduced brain blood flow could be central to all 3 conditions.

This study aims to investigate brain structural, neuro-vascular, and biochemical differences between groups to deepen our understanding of ME/CFS, LC and POTS pathology and develop effective treatments. By examining astrocyte activity, metabolic variations, cerebral blood flow responses to exercise, and neuroinflammatory markers, we seek to uncover key mechanisms driving ME/CFS symptoms and identify potential therapeutic targets.

OBJECTIVES

we see a PET (Positron Emission Tomography) scan in progress within a medical facility. The patient is lying on a narrow bed that is part of the PET scanning machine.

  1. Investigate astrocyte activity and glucose hypometabolic patterns to elucidate brain neuroinflammation mechanisms in ME/CFS and LC.
  2. Analyze metabolite variations, particularly glutamate and GABA levels, in the hypothalamus among ME/CFS and LC patients compared to controls.
  3. Explore correlations with central nervous system neuroinflammation, blood hormone levels, and symptom manifestation.
  4. Assess changes in cerebral blood flow during exercise in ME/CFS and POTS patients, both globally and regionally in the brain. Investigate potential synergistic effects in individuals with comorbid ME/CFS and POTS.
  5. Evaluate the impact of cerebral blood flow alterations on symptomatology and post-exertional malaise severity in ME/CFS, LC and POTS populations.
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.


How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669